Drug
FP Mdpi
FP Mdpi: highest development phase Phase 3, developed by Teva. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fp MDPI NCT02175771 | Phase 3 | Persistent Asthma |
| Fp MDPI NCT01772368 | Phase 2 | Asthma |
Latest
No recent events.
Follow FP Mdpi on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.